anterior plate to enhance the stability to reduce graft-related complications and increase fusion rates (11, 24) .
█ INTRODUCTION
Since its introduction proposed by Smith and Robinson (1958) (21) , anterior cervical discectomy and fusion (ACDF) has become the "gold standard" treatment of degenerative cervical disc disease (DCDD) for elderly patients or patients with contra-indications for disc prosthesis (10) . Although the use of autologous iliac bone can provide solid fusion, the incidence of donor-site morbidity and complications including hematoma formation, pain, infection and neurological injury were still not negligible. To avoid these problems, varieties of cervical cages have been developed (7, 29) . Considering that the stand-alone cages are associated with high incidences of implant subsidence, many surgeons prefer to add an To avoid these complications, a new Zero-profile anterior cervical interbody fusion device, the Zero-P (Synthes GmbH Switzerland, Oberdorf, Switzerland), was developed and approved to use for patients with DCDD by the united States Food and Drug Administration in 2008. In this system, a designed plate with four angle-controlled screw trajectory, where screws could get into the vertebral body through the end plate, is attached to the front of the cage. The whole device can be implanted into the intervertebral space to avoid the implant contact to the front soft tissue of the cervical. It has been shown to provide similar biomechanical stability to that of fusion using cervical cage and plate constructs (18) . Early results have shown neurological improvement and infrequent post-operative dysphagia (14, 19, 30) . In this study we compared the early clinical outcome and complications between Zero-P implant and cage with anterior plate in patients with DCDD undergoing ACDF.
█ MATERIAL and METHODS
Between May 2010 and May 2012, 50 selected patients (24 male, 26 female) who underwent ACDF were enrolled prospectively. All patients had cervical radicular symptoms or neurological deficits failing conservative treatment for at least 6 weeks. 23 patients with a mean age of 48.6 years (range 33-65 years) had a total of 27 Zero-P implanted. Another 27 patients, with a mean age of 52.7 (range 36-72 years), had a common cage implanted with an anterior titanium plate. The mean follow-up time ranged from 24 to 36 months (mean 28.5 months). Both groups were comparable regarding the characteristics of the patients. (Table I) .
Preoperative anteroposterior (AP) and lateral radiographs, computed tomography (CT) and magnetic resonance imaging (MRI) scans were obtained (Figures 1A-D ; 2A-D; 3A-D). All patients underwent a right-sided Smith-Robinson approach. The Zero-P device contains a polyether ether ketone (PEEK) body with tantalum markers to control the position during insertion. Correct position of the Zero-P was controlled by using an image intensifier in lateral and AP views. The device should be placed 2 mm behind the anterior column in the lateral view and in the center of the disc space in the AP view (19) . The anterior plate was Slim-Loc (Johnson & Johnson Co., DePuy Spine Ltd., Raynham, Massachusetts). All patients wore a Philadelphia collar for one month post-operatively.
Preoperative and Post-operative clinical evaluation were done by a team comprising a neurologist, pain specialist and a neurosurgeon. This included the Japanese Orthopaedic Association (JOA) score for neurological function, Neck Disability Index (NDI) score for neck function and Short form 36 (SF-36) for the general quality of life. Incidence of dysphagiarelated symptoms were graded depending on the patient's state as none (no episodes of swallowing problems), mild (rare episodes of dysphagia), moderate (occasional swallowing difficulty with specific food), and severe (frequent difficult swallowing with majority of food) according to Bazaz et al.
(2). Plain radiographs (AP and lateral views) were performed 2 days postop and at each follow up (3 months, 12 months, and 24 months). The predominant swelling of the prevertebral soft tissue was observed at the C3 level after ACDF operation, and thus the degree of cervical prevertebral soft tissue was measured as the distance between the anterior surface of C3 vertebral body and the air shadow of the airway (22, 26) . In the area where the plate was fixed, the distances from the anterior margins of the plates to a shadow were measured. The Cobb angle, measured as the acute angle constructed by the lines going along the back of C2 and C7 vertebral body on the standing lateral cervical X-ray, was used to evaluate the sagittal alignment of the cervical spine (16).
Data were analyzed using SPSS 16.0. The paired t-test was used to assess the difference of aimed outcomes before and after operation. Pearson Chi-Square c 2 test was used to assess the difference in dysphagia rates. A p-value of <0.05 was considered significant.
█ RESULTS
The JOA and SF-36 scores significantly increased and the NDI score dropped compared to the preoperative values at followup time (p<0.05), but without significant differences during the follow-up period in both groups (p>0.05) ( Table II) .
All patients achieved solid fusion and no implant displacement was observed at final follow-up in both groups (Figure 4A-D; 5A-D; 6A-D). The cervical sagittal alignment had a significant correction (from 9.4° to 13.8° in Zero-P group (p<0.05) and from 10.1° to 14.8° in the cage with plate group (p<0.05)) and was maintained well (Table III) . The thickness of the prevertebral soft tissue at 2 days and 3 months postoperatively was significantly lower in the Zero-P group than that in the cage with plate group (p<0.05), but without significant differences at 12 and 24 months follow-up (p>0.05) (Table III) .
In the Zero-P group, 5 of 23 patients (21.7%) had transient postoperative mild dysphagia (<3 months) and only 1 patient complained of moderate dysphagia that persisted beyond 3 months in the cage with plate group. As for these 7 patients, 4 were released at the 6 months follow-up, 2 released at the 12 months follow-up and still one female complained of mild dysphagia at final follow-up. Thus, the incidence of dysphagia in the Zero-P group was significantly lower than that in the Cage with plate group (p<0.05), and the duration was much shorter (p<0.05) (Table IV) .
No iatrogenic tracheal, esophageal, or vascular injuries related to the operation occurred. Additional complications included one case of cerebrospinal fluid leakage in each group. Both patients recovered after 5 to 7 days of local pressure and conservative treatment. One patient suffered from a postoperative superficial wound infection in the Zero-P group and the infection resolved after treating with antibiotics. We had two patients with hoarseness of voice who resolved in 5 months in the cage with plate group.
(4.3%) complained of dysphagia that persisted beyond 3 months who was also released at the 6 months follow-up. However, 13 of 27 patients (48.1%) had transient postoperative dysphagia (9 mild, 4 Moderate) and 7 patients (25.9%) For patients with DCDD where conservative treatment fails, ACDF is a well-established treatment to re-build intervertebral height and cervical lordosis. At present, various cages are widely used for interbody fusion to avoid morbidity at the donor site and complications arising from the use of autologous iliac bone. Surgeons also prefer to add an anterior plate to enhance rigidity of fixation especially in multi-level cases (11, 23, 24) . Although the design of the current anterior plate has been improved over the years, the complications related to the plates are still not rare, and include screw loosening or breakage, plate breakage, and screw pullout with or without migration into the gastrointestinal tract (15, 25) .
The stand-alone Zero-P device is designed to avoid these complications by combining interbody fusion and supplemental plate fixation into the cage. In our study, the Zero-P device is 
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Another possible mechanism for high postoperative dysphagia rate following ACDF with plate may be the additional traction and more time needed to control the angle of the screws and length of the plate to place the plate correctly (11, 14, 15) . Increased pressure on the esophagus during implantation of the plate and direct stimulus of esophagus may contribute to the dysphagia (5, 31). The Zero-P device can be inserted into the disc space directly and the screws can be easily installed with the help of the trajectories. Thus smaller operative field and fewer steps are needed to place the Zero-P with only a little part of the upper and lower vertebrae of the responsible segment exposed, and the one-step locking mechanism with simple insertion of the cage and tightening of the screws (16) . The less esophagus retraction extent and less intraoperative retraction time to install the Zero-P device may also contribute to the lower rate of dysphagia (17) .
The use of the Zero-P device still has some disadvantage especially in the upper and lower cervical spine (19) . It was easy to use the implant in the levels C4/C5, C5/C6 and C6/C7. Below and above, especially in patients with a short neck or high sternum, the lower screws of C3/4 and the upper screws of the C6/7 segment are hard to introduce at an optimal angle, even with the help of angled instruments. A wider skin incision and increased retraction may be needed.
█ CONCLUSION According to our study, the primary clinical and radiographic efficacy of Zero-P used in ACDF is satisfactory in a relatively large number of patients over a minimum 2-year follow-up and can be used as a valid alternative to anterior cervical plating. The incidence of postoperative dysphagia was lower and the duration was shorter in the Zero-p group compared to the cage with plate group. More patients and longer follow-up periods are needed for further confirmation of the results we have obtained in this study. confirmed to provide similar biomechanical stability to that of fusion using an anterior plate and cage and both procedures correct and maintain cervical kyphosis and improve cervical alignment. When referring to the clinical effectiveness measured by JOA and NDI score, the neurological function and symptoms all had significant improvement in the Zero-P group which was similar to the effectiveness of the cage with plate group.
The SF-36 has been widely used in many ACDF and cervical disc prosthesis procedures as an important integral part in evaluating the success of a specific medical treatment (1, 3 The incidence, severity and duration of dysphagia in our Zero-P group was similar to that of Scholz and Hofstetter (6, 19) who used Zero-P implants with lower incidence of transient and chronic dysphagia postoperatively and was much less than that in our cage with plate group and other investigators (8, 20, 32) . A relationship between postoperative swelling of the prevertebral soft tissue and postoperative dysphagia has been reported (22, 26) . Increased thickness of the prevertebral soft tissue is also considered a risk factor of dysphagia. The mean thickness of the prevertebral soft tissue was less in the Zero-P group in the first 3 months and resulted in lower incidence and duration of dysphagia.
The presence of the plate itself in front of the anterior cervical and its irritation of the esophagus is considered to be a possible cause of postoperative dysphagia (27) . It has been shown that plates with smoother surface can reduce the chance of irritating or impinging the esophagus and the occurrence of dysphagia (12, 32) . The significantly lower incidence of postoperative dysphagia in patients after cervical arthroplasty as compared with those treated with cage and plate also confirmed this theory (13) . The Zero-P device can be inserted directly into the disc space and avoids direct contact with the soft tissue in front of the cervical to prevent mechanical irritation of the esophagus. This may also explain the lower thickness of the prevertebral soft tissue in our Zero-P group.
